Emma Lees

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

Association of human cyclin E with a periodic G1-S phase protein kinase

Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening

Raf-Induced Proliferation or Cell Cycle Arrest Is Determined by the Level of Raf Activity with Arrest Mediated by p21^Cip1

Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5

Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor

Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.

BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.

A human RNA polymerase II complex associated with SRB and DNA-repair proteins

The cdk2 kinase is required for the G1-to-S transition in mammalian cells.